DA32 Life Science Tech Acquisition Corp. (DALS)

Market Cap	258.30M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	25.65M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3
Open	10.02
Previous Close	10.07
Day's Range	10.02 - 10.08
52-Week Range	9.59 - 10.61
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DALS

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Jul 28, 2021
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: DALS